Skip to main navigation

This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience.

Read our cookie policy for more information.
Click here to accept the use of cookies on our website.
Genmab
  • Careers
  • Contact us
  • About Us
    • Company Overview
    • Strategy
    • Our Vision
    • Senior Leadership
    • Board of Directors
    • History
    • AGM 2018
  • Product Pipeline
    • Products in development
      • Daratumumab
      • Ofatumumab
      • Tisotumab vedotin
      • Enapotamab vedotin (HuMax-AXL-ADC)
      • HexaBody-DR5/DR5
      • DuoBody-CD3xCD20
      • Teprotumumab
      • Camidanlumab tesirine
      • HuMax-IL8
      • JNJ-61186372
      • JNJ-63709178
      • JNJ-64007957
      • JNJ-64407564
      • Pre-clinical
    • Clinical Trials
  • Research and Technology
    • Introduction to antibodies
    • Genmab antibody discovery
    • Genmab technology
  • Partnering
    • Our approach
    • Current partnerships
    • Licensing opportunities
      • Technology
  • Investors
    • Genmab News
    • Financial Reports
    • Consolidated Key Figures
    • Stock Information
      • Analyst Coverage
      • Major Shareholders
      • Warrants
      • Restricted Stock Units
    • ADR Program
    • Events & Presentations
    • Financial Calendar
    • Annual General Meeting
    • Investor Portal
    • Corporate Governance
      • Articles of Association
      • Board Committees and Charters
      • Remuneration Principles
    • Corporate Social Responsibility
    • Email Alert Subscription
    • IR Policy
    • FAQ
    • Contact
  • Media
  • Contact Us
    • Office locations
    • Contact form
  • Careers
    • Our culture
    • Meet the team
    • Benefits
    • Current vacancies
  • Privacy
    • Applicants HR Genmab A/S
    • Applicants HR Genmab B.V.
    • Shareholders Genmab A/S
    • IR Subscriptions, Webcasts, Conference Calls
    • Clinical Trials
      • GCT1015-04
      • GCT1021-01
      • GCT1015-05
    • Website Inquiries and Website Use
  • Home >>
  • Investors >>
  • Corporate Governance >>
  • Articles of Association
  • Investors
  • Genmab News
  • Financial Reports
  • Consolidated Key Figures
  • Stock Information
  • ADR Program
  • Events & Presentations
  • Financial Calendar
  • Annual General Meeting
  • InvestorPortal
  • Corporate Governance
    • Articles of Association
    • Remuneration Principles
    • Board Committees and Charters
  • Corporate Social Responsibility
  • IR Policy
  • FAQ
  • Contact

Shareholder Tools

  • Email Alerts
  • Download Library
  • Snapshot
  • RSS News Feeds

Articles of Association

Articles of Association

Title View
Articles of association dated April 02, 2019 – English
Articles of association dated April 02, 2019 – English
Articles of association dated April 02, 2019 – Danish
Articles of association dated April 02, 2019 – Danish

Shareholder Tools

  • Email Alerts
  • Download Library
  • Snapshot
  • RSS News Feeds
  • Accessibility policy
  • Cookie policy
  • Disclaimer
  • Privacy
  • Sitemap
     
   
© 2019 Genmab A/S